Turnaround time — universally abbreviated as TAT — is one of the most searched and most debated concepts in laboratory testing, and for good reason. Whether you are a clinician waiting for a sepsis panel result in the emergency department, a pharmaceutical quality assurance manager waiting for a certificate of analysis before releasing a drug batch, or a food safety director waiting for pathogen screen results before approving a product shipment, TAT directly determines how fast you can act on laboratory data.
Yet TAT is frequently misunderstood — or measured and communicated inconsistently — which creates friction between laboratories and the clients, clinicians, and regulators who depend on their results. A laboratory that quotes a “5-day TAT” and a client who expects results in 5 calendar days from sample collection may both be disappointed to learn that the lab is counting from sample receipt and the client is counting from shipment. These definitional gaps cost time, trust, and sometimes money.
This guide covers everything you need to know about laboratory TAT: the definitions, the phases, the benchmarks, the regulatory requirements, and — critically for anyone outsourcing laboratory testing to a contract lab — how to specify, negotiate, and evaluate TAT when selecting a testing partner.
What Is Turnaround Time (TAT) in Laboratory Testing?
Laboratory turnaround time (TAT) is a performance metric that measures the time elapsed between two defined points in the laboratory testing process. The challenge is that those two points are not universally standardized — different laboratories, regulatory frameworks, and clinical contexts define TAT differently. The key definitions are:
- Intra-laboratory TAT (receipt-to-result). The most common definition in laboratory operations is time from when the sample is received and accepted at the laboratory to when the final result is reported or dispatched. This is typically what contract testing laboratories quote when they advertise a TAT. It does not include sample collection, packaging, or shipping time.
- Order-to-result TAT. The time from when a test is ordered (or a sample collection kit is dispatched) to when results are received by the requester. This is the clinician’s or client’s real-world experience of TAT and is typically longer than intra-lab TAT.
- Total (“brain-to-brain”) TAT. The broadest definition encompasses the full cycle from the clinical or commercial question that prompted testing to the point where the result informs a decision or action. This is used in healthcare quality improvement and laboratory accreditation contexts to capture the full impact of laboratory services.
- STAT TAT. The turnaround time for urgent or emergency testing orders is typically dramatically shorter than routine TAT. In clinical laboratories, STAT tests are often processed immediately on receipt, outside the normal batch schedule.
Key practical note for contract lab buyers: When a contract testing laboratory quotes a TAT of “3-5 business days,” confirm whether that clock starts at sample receipt at the laboratory or at sample collection/shipment. For samples requiring overnight shipping, the effective total TAT from your facility could be 5-7 days or more. Always clarify the TAT definition in writing before placing a testing order.
The Three Phases of Laboratory TAT
Peer-reviewed laboratory literature consistently frames TAT around three sequential phases of the testing process, each with its own sources of delay. Understanding these phases helps both laboratories and their clients identify where time is lost and where improvement efforts will have the greatest impact.
1. Pre-Analytical Phase
The pre-analytical phase encompasses everything that happens before a sample reaches the analytical instrument: test ordering, sample collection, labeling, packaging, transportation to the laboratory, receipt and acceptance at the laboratory (including chain-of-custody verification), registration in the laboratory information management system (LIMS), and sample preparation (extraction, digestion, dilution, preservation, centrifugation, etc.).
Pre-analytical errors and delays are the most common source of TAT failure. In clinical laboratories, studies consistently show that 46–68% of laboratory errors occur during the pre-analytical phase. For contract testing laboratories, the most frequent pre-analytical delay causes are: incorrect or incomplete sample labeling; improper sample preservation or container selection; samples arriving outside of required hold times; insufficient sample volume; and incomplete or missing chain-of-custody documentation.
For outsourced testing, the pre-analytical phase is largely in the client’s hands, which means the buyer has significant control over effective TAT. Well-prepared, correctly labeled, properly preserved samples with complete documentation will always produce faster results than problematic samples that require follow-up, recollection, or reprocessing.
2. Analytical Phase
The analytical phase is the core testing process: the sample is loaded onto the analytical instrument or subjected to the test method, and raw data is generated. This phase is where the laboratory’s technical expertise, equipment quality, and method efficiency are most directly expressed.
Factors affecting analytical phase TAT include: instrument queue and batch scheduling (many routine tests are batched to maximize efficiency, meaning your sample may wait for a full batch before processing begins); method-specific analysis time (a simple pH measurement takes seconds; an LC-MS/MS drug concentration method takes 15-30 minutes; a 14-day microbial growth assay takes, by definition, 14 days); quality control procedures that must be completed before results can be released; and instrument downtime for maintenance or calibration.
This is why TAT varies so enormously by test type — not because different labs work at different speeds, but because the underlying scientific method dictates the minimum time required. A Salmonella culture result cannot be reported in 24 hours; a water pH result can be reported in minutes.
3. Post-Analytical Phase
The post-analytical phase covers everything after the raw analytical data is generated: results review and verification by a qualified analyst or laboratory director; data entry into the LIMS or reporting system; report generation; quality assurance sign-off; and final delivery of the report to the requesting party (upload to a portal, email dispatch, fax, or physical mail).
Post-analytical delays are often overlooked but are a meaningful contributor to overall TAT. Manual data transcription, fragmented reporting systems, bottlenecks in the review queue, and poor communication between the laboratory and client all extend post-analytical phase time. Modern laboratory information management systems (LIMS) with automated report generation and portal delivery can dramatically reduce post-analytical phase TAT.
Typical TAT Benchmarks by Testing Type
TAT varies enormously across laboratory testing disciplines. The table below provides representative typical TAT ranges for common testing categories, distinguishing between STAT/rush and standard/routine options. These ranges reflect general industry practice; actual TAT depends on the specific test method, laboratory workload, and sample quality.
| Testing category | Routine TAT | STAT / Rush TAT | Key method factors | Common use cases |
| Clinical chemistry (glucose, electrolytes) | 30–60 min | 10–20 min | Fully automated analyzers; 24/7 operation in hospital labs | Emergency diagnosis, routine monitoring |
| Microbiology — culture & sensitivity | 2–5 days | 24–48 hr (prelim report) | Incubation time is fixed; organism growth cannot be accelerated | Infection diagnosis, food pathogen testing |
| Molecular / PCR testing | 24–72 hr | 2–6 hr (rapid PCR) | Instrument throughput; sample prep time; batch vs. on-demand processing | Pathogen ID, genetic screening, viral load |
| Environmental water testing | 5–10 business days | 2–3 business days | Method hold times (coliform 6–24 hr); sample preservation requirements | Compliance testing, site assessment |
| Pharmaceutical — HPLC assay/purity | 5–14 business days | 2–5 business days | Extraction, cleanup, multi-method analysis; QC batch scheduling | Regulatory compliance, site remediation |
| Stability testing (pharma/cosmetics) | 5–10 business days | 2–3 business days | Method development/validation status; column equilibration; batch scheduling | QC release, stability testing, COA generation |
| Food safety — chemistry (pesticides, metals) | 3–7 business days | 1–3 business days | Multi-residue panel complexity; sample matrix preparation; ICP-MS batch runs | Regulatory compliance, product release |
| Materials testing (metals, composites) | 5–15 business days | 3–5 business days | Sample preparation (cutting, mounting, polishing); instrument availability; complexity of analysis | Product QC, failure analysis, specifications |
| Stability testing (pharma / cosmetics) | Defined by protocol (weeks–months) | N/A — fixed by study design | Real-time or accelerated stability conditions; time points defined by ICH guidelines | Regulatory submission, shelf life determination |
Important: Rush or expedited testing typically adds a 25–75% premium to standard pricing, depending on the laboratory and test type. Some methods cannot be rushed, regardless of priority — methods with fixed incubation periods (microbiological cultures, stability studies) cannot be accelerated by paying a rush fee. Always verify with the laboratory which tests are eligible for rush processing.
Regulatory and Accreditation Requirements for Laboratory TAT
Several regulatory frameworks and accreditation standards address TAT as a quality indicator, each with different scope and specificity.
CLIA (Clinical Laboratory Improvement Amendments)
In the United States, clinical laboratories are regulated under the Clinical Laboratory Improvement Amendments (CLIA) administered by the Centers for Medicare and Medicaid Services (CMS). CLIA regulations require that laboratories have systems in place to ensure timely reporting of test results and that there are documented procedures for notifying ordering providers of critical values (life-threatening results) immediately. However, CLIA does not set universal numerical TAT targets — those are typically set by the laboratory itself, by accrediting bodies, or by institutional policy.
CAP (College of American Pathologists) Accreditation
The College of American Pathologists (CAP) accreditation program requires laboratories to establish TAT goals, monitor performance against those goals, and take corrective action when goals are consistently missed. CAP-accredited laboratories must demonstrate an active TAT monitoring program as part of their quality management system. This gives buyers of clinical reference laboratory services additional assurance that the laboratory actively manages TAT performance.
ISO 15189 (Medical Laboratories)
ISO 15189 — the international standard for the quality and competence of medical laboratories — requires that laboratories define and document TAT objectives, communicate these to users, monitor their TAT performance, and take appropriate corrective action when TAT requirements are not met. ISO 15189-accredited laboratories are independently assessed against these requirements, providing a quality benchmark for medical laboratory TAT management.
ISO/IEC 17025 (Testing and Calibration Laboratories)
For commercial contract testing laboratories (environmental, pharmaceutical, food, materials, and others), ISO/IEC 17025 is the applicable quality standard. While ISO/IEC 17025 does not mandate specific TAT targets, it requires that the laboratory have a documented system for communicating TAT commitments to clients, managing client expectations regarding test timing, and addressing situations where committed TATs cannot be met. An ISO/IEC 17025-accredited laboratory has been independently assessed for its quality management practices, including its handling of TAT commitments.
Regulatory Method-Specific TAT Requirements
Some regulatory testing programs impose mandatory TAT requirements that override laboratory preferences. Examples include: EPA Method hold times (the maximum time allowed between sample collection and analysis, which is legally enforceable for environmental testing); FDA-regulated pharmaceutical testing timelines; USDA food pathogen testing reporting requirements; and clinical laboratory critical value reporting windows under CLIA and JCAHO standards. Understanding whether your testing program has mandatory TAT requirements — not just aspirational targets — is essential when selecting and contracting with a testing laboratory.
Why TAT Matters: Clinical, Commercial, and Regulatory Implications
Clinical Impact
In healthcare settings, TAT directly affects patient outcomes. Rapid diagnosis of sepsis, myocardial infarction, stroke, and other time-critical conditions depends on fast laboratory results. Studies have demonstrated that delays in laboratory TAT are associated with extended emergency department stays, delayed treatment initiation, and increased adverse outcomes. Point-of-care testing (POCT) has emerged largely as a TAT-driven innovation — placing testing at the bedside eliminates pre-analytical transportation time and can reduce effective TAT for critical tests from hours to minutes.
Pharmaceutical and Biopharmaceutical Impact
In pharmaceutical manufacturing and drug development, TAT governs how quickly batches can be released, how fast development compounds can be evaluated, and how rapidly regulatory submissions can be prepared. A pharmaceutical company waiting on a certificate of analysis (COA) from a contract testing lab cannot release its product for commercial sale until that document is in hand. In clinical trials, the bioanalytical result TAT affects how quickly data can be analyzed and interim analyses conducted.
Food Safety Impact
For food and beverage manufacturers, TAT determines product release schedules. A food producer whose batch is on hold pending microbiological test results is incurring real warehouse and perishability costs for every day of delay. In outbreak investigations, rapid pathogen identification is essential for containing contamination events. Some food testing programs have specific regulatory TAT requirements — for example, certain USDA FSIS testing protocols require results within defined windows.
Environmental and Industrial Impact
Environmental site managers, remediation contractors, and industrial facilities commissioning environmental testing are often working against regulatory reporting deadlines. EPA method hold times for certain analytes (particularly volatile organics and microbiological parameters in water) mean that analytical results must be produced within a fixed window from sample collection — the laboratory’s TAT is not just a service metric, it is a regulatory compliance requirement.
TAT When Outsourcing to a Contract Testing Laboratory
For buyers of contract laboratory testing services — whether pharmaceutical companies, food producers, environmental consultants, manufacturers, or research institutions — TAT considerations in outsourced testing have several dimensions that do not apply to in-house laboratory settings.
What Affects TAT in Contract Testing
- Sample shipping time. Unless your facility is local to the laboratory, sample transit time adds to total effective TAT. An overnight courier delivers in roughly 24 hours under normal conditions; international shipping can add 3-5 days or more. All of this elapsed time counts against method hold times but is not included in the laboratory’s quoted TAT.
- Batch scheduling. Most analytical instruments in contract labs are run in batches to maximize efficiency and QC integrity. Your samples may arrive on a Wednesday but not be added to the analytical batch until Thursday or Monday, depending on the lab’s scheduling. Understanding a laboratory’s batch frequency for your specific test is essential for realistic TAT planning.
- Sample acceptance and hold time verification. Contract labs must verify that samples were properly collected, preserved, and shipped within method-required hold times before they are accepted for testing. Samples that arrive out of hold or improperly preserved are rejected — and the TAT clock must restart from recollection.
- Method complexity and subcontracting. Some specialized tests may be subcontracted by the primary lab to a reference laboratory. Subcontracting adds transit time and may extend TAT significantly. If TAT is critical, confirm whether the laboratory performs the test in-house or subcontracts it.
- Quality control and review cycles. Accredited laboratories must complete a full QC review before releasing results. If QC fails, the batch must be repeated — adding a full analytical cycle to TAT. Rush fees do not accelerate QC review requirements.
How to Specify TAT in a Contract Lab Testing Request
When submitting a laboratory testing request on ContractLaboratory.com or directly to a contract laboratory, be explicit about your TAT requirements using the following framework:
- State your required TAT and its starting point. “I need results within 5 business days of sample receipt at your facility” is unambiguous. “I need results within 5 days” is ambiguous — from collection? from shipment? from receipt?
- Distinguish routine from rush needs. If you have some samples that are time-critical and others that are not, state this clearly. Rush processing for an entire project when only a subset requires urgency adds unnecessary cost.
- Confirm hold time compliance. Ask the laboratory to confirm that your specified TAT is achievable, given the hold time requirements for your analytes and the expected shipping time. This is particularly important for environmental samples and microbiological testing.
- Ask about batch frequency. “How often do you run batches for this test?” is a question that dramatically affects effective TAT. A lab that batches twice a week means your samples could sit for up to 4 days before analysis begins.
- Request confirmation of in-house capability. “Is this test performed in your facility, or is it subcontracted to a reference laboratory?” If subcontracted, ask for the reference lab’s typical TAT and the total estimated elapsed time.
- Agree on failure notification. Specify what happens if the TAT commitment cannot be met. Require the laboratory to notify you proactively if QC failure or other issues will delay results, rather than discovering a delay when the expected delivery date passes without results.
ContractLaboratory.com’s laboratory testing request platform allows you to specify your TAT requirements as part of your request, enabling laboratories to confirm their ability to meet your timeline before you commit to the engagement.
Strategies for Optimizing Laboratory TAT
For Laboratory Professionals
- Lean methodology and value stream mapping. Mapping the entire testing workflow from sample receipt to result delivery identifies non-value-added steps, waiting times, and handoff delays. Lean tools — particularly 5S, Kanban, and value stream analysis — have been validated in multiple peer-reviewed studies as effective for reducing clinical laboratory TAT by 30–50% without capital investment.
- Laboratory automation. Automated sample processing, track systems, and integrated analyzers reduce manual handling time, eliminate transcription errors, and enable 24/7 sample throughput without proportional staffing increases. In high-volume clinical labs, automated core laboratory systems can dramatically compress pre-analytical phase time.
- LIMS implementation and optimization. A well-implemented Laboratory Information Management System eliminates manual result transcription, automates QC checks, enables electronic report delivery, and provides real-time TAT monitoring dashboards that identify bottlenecks before they become systemic problems.
- Critical value and STAT escalation protocols. Clear, tested protocols for triaging urgent samples, communicating critical values, and escalating to supervisors when TAT goals are at risk prevent individual delays from becoming systemic failures.
- Staff training and workload distribution. Cross-training laboratory personnel on multiple instrument platforms reduces bottlenecks caused by staff absence. Balanced workload distribution prevents individual analysts from becoming single points of failure in the TAT chain.
For Buyers of Contract Testing Services
- Prepare samples correctly the first time. Sample rejection due to improper collection, labeling, or preservation is the single most controllable cause of TAT extension in outsourced testing. Investing in proper training for sample collection personnel and using laboratory-provided collection kits eliminates a major source of delay.
- Ship proactively, not reactively. Shipping samples at the start of the week rather than Thursday or Friday ensures they arrive at the laboratory before the weekend, preventing samples from sitting in a shipping depot or on a laboratory dock for two days before processing begins.
- Use a LIMS or project management portal. Tracking sample status in real time — from shipment through receipt, analysis, and report delivery — prevents the uncertainty that leads to unnecessary phone calls and email inquiries, and provides early warning of delays.
- Build relationships with preferred laboratories. Laboratories prioritize established clients. A manufacturing company that sends consistent, high-quality samples, pays promptly, and communicates clearly will typically receive faster service than a one-off client with problematic samples. ContractLaboratory.com’s network enables you to build preferred lab relationships at scale.
How ContractLaboratory.com Supports Your TAT Requirements
ContractLaboratory.com operates the world’s largest laboratory outsourcing network, connecting organizations with accredited contract testing laboratories for every testing discipline — pharmaceutical and biopharmaceutical testing, environmental analysis, food and beverage testing, microbiology and pathogen detection, chemistry and compound analysis, and many others.
When you submit a laboratory testing request, you can specify your TAT requirements directly in your submission. Laboratories in the network respond with proposals that include their quoted TAT for your specific test — allowing you to compare turnaround time alongside capability, accreditation, and pricing before committing. If your need is urgent, you can explicitly request rush or expedited testing, and laboratories with the capacity to meet your timeline will identify themselves in their proposals.
For organizations with ongoing or recurring testing needs — where TAT consistency is as important as speed — ContractLaboratory.com can help you identify and qualify preferred laboratory partners who understand your testing program, your sample types, and your TAT requirements. Contact our team for guidance on building a contract laboratory qualification program tailored to your industry.
Frequently Asked Questions About Laboratory TAT
TAT stands for turnaround time — the time elapsed between two defined points in the laboratory testing process. In most laboratory contexts, TAT refers to the intra-laboratory turnaround time: the time from when a sample is received and accepted at the laboratory to when the final result report is released. However, the definition varies: some use “order-to-result TAT” (from when testing is ordered), and others use “total TAT” or “brain-to-brain TAT” (from the clinical question to the action taken on the result). When evaluating a laboratory’s quoted TAT, always confirm which definition they are using.
STAT (from the Latin statim, meaning “immediately”) refers to urgent testing that requires the fastest possible processing. STAT samples are typically given priority over the normal batch queue and are processed as soon as they are accepted. In clinical laboratories, STAT TAT for basic chemistry tests is commonly 30–60 minutes. Routine TAT applies to non-urgent tests processed in the normal batch workflow, which may be run once or twice per day. In contract testing, “rush” or “expedited” testing is the equivalent of STAT — it typically costs 25–75% more than standard pricing and moves samples to the front of the processing queue.
The pre-analytical phase covers everything before testing begins: sample collection, labeling, transport, receipt at the laboratory, chain-of-custody verification, LIMS entry, and sample preparation. The analytical phase is the core testing process on the instrument. The post-analytical phase includes results verification, report generation, QA sign-off, and result delivery. Research consistently shows that the pre-analytical phase is where the majority of delays and errors occur — up to 70% in some studies. For buyers of outsourced testing, much of the pre-analytical phase is in the client’s control and is the most accessible target for reducing effective TAT.
It depends entirely on the test type and the laboratory’s batch scheduling. Simple, automated clinical chemistry tests (glucose, electrolytes) can be completed in under an hour in an in-house lab. Microbiological culture tests require 24–72 hours at minimum due to biological growth time. Environmental water testing typically takes 5–10 business days. Pharmaceutical HPLC testing commonly takes 5–10 business days. Materials testing can take 1–3 weeks. Some tests — like stability studies or bioassays — are governed by fixed protocol timelines and cannot be accelerated regardless of priority.
Look for: (1) a clear definition of when their TAT clock starts — sample receipt, not sample collection or shipment; (2) whether the quoted TAT is in business days or calendar days; (3) whether the test is performed in-house or subcontracted to a reference lab; (4) batch frequency — how often they run the specific test; (5) their policy on notifying clients proactively when committed TATs cannot be met; (6) whether they offer rush or expedited options for your test type and what the associated cost premium is; and (7) any method-specific hold time constraints that cap the achievable TAT.
Yes — most contract laboratories offer expedited or rush testing options for tests that are not constrained by fixed biological or chemical timelines. Rush testing typically involves prioritizing your samples at the front of the analytical queue and may involve weekend or after-hours processing. However, not all tests can be rushed — microbiological incubation periods, stability study timepoints, and certain reaction-time-dependent assays have scientifically fixed minimum durations that no amount of priority processing can shorten. When submitting a testing request on ContractLaboratory.com, you can specify your required TAT and receive proposals only from laboratories able to meet your timeline.
In the US, clinical laboratories are regulated under CLIA (Clinical Laboratory Improvement Amendments), which requires timely reporting and immediate notification of critical values but does not set universal numerical TAT targets. CAP accreditation requires TAT goal-setting and monitoring. ISO 15189 (medical labs) requires documented TAT objectives and monitoring. ISO/IEC 17025 (commercial contract labs) requires TAT commitments to be documented and honored. Some regulatory testing programs impose mandatory TAT deadlines — EPA method hold times for environmental samples are the most notable example, as they are legally binding and their violation can render analytical results invalid.
Standard TAT is priced into the base testing cost. Rush or expedited testing typically carries a premium of 25–75% above the standard price, reflecting the additional operational cost of prioritizing samples outside the normal batch workflow, potential overtime processing, and dedicating dedicated instrument time to urgent samples. Some laboratories charge a flat rush fee; others charge a percentage premium. Weekend or holiday processing may have additional surcharges. When evaluating cost proposals from contract laboratories on ContractLaboratory.com, always confirm whether the quoted price reflects standard or expedited TAT.
Total TAT — sometimes called “brain-to-brain TAT” in the clinical literature — measures the complete cycle from the initial clinical or commercial question that prompted testing, through sample collection, transport, laboratory analysis, result delivery, and interpretation, to the point where the result leads to an action or decision. This is the most clinically meaningful measure of laboratory impact because it captures the total time from need to action, not just the in-lab processing time. Most laboratories do not report brain-to-brain TAT because much of it falls outside their control, but it is the metric most relevant to evaluating the actual value of laboratory testing in a clinical or supply-chain context.
Conclusion
Turnaround time is not simply a metric of how fast a laboratory can process samples — it is a measure of how effectively the entire testing ecosystem, from sample collection through result delivery, serves the needs of patients, clinicians, manufacturers, and regulators who depend on laboratory data to make critical decisions.
For buyers of contract testing services, TAT is a key criterion in laboratory selection — but only when evaluated with precision. Understanding what a laboratory means when it quotes a TAT, what factors within and outside the laboratory’s control affect that TAT, and how to specify your requirements clearly when submitting a testing request are the practical skills that translate into consistently on-time results.
ContractLaboratory.com gives you the tools to find laboratories that can meet your TAT requirements across every testing discipline. Submit a testing request and specify your timeline, or browse our global directory of accredited contract testing laboratories to find the right partner for your testing program. For guidance on evaluating laboratory capabilities, including TAT performance, contact our team.